Table 2.

Outcome measure Baseline values, Pearson correlation coefficients, and change in outcome measures from Baseline to Week 8. (95% confidence intervals)

Selected outcome measures	Baseline (mean ± SE)	TT Baseline correlated * to Baseline outcome values	Change Baseline to Week 8 (mean ± SE)	TT change correlated * to change from Baseline to Week 8
Tampon test	4.67 ± 0.19	1.00	−1.53 ± 0.19	1.00
Overall pain (24 hrs.)	1.90 ± 0.16	0.38 (0.23, 0.52); P < 0.0001	−0.60 ± 1.19	0.42 (0.24, 0.55); P < 0.0001
Intercourse pain	5.82 ± 0.24	0.22 (0.05, 0.38); P = 0.04	−1.60 ± 0.23	0.35 (0.17, 0.50); P = 0.003
CST (vestibule)	22.12 ± 0.46	0.11 (−0.06, 0.28); P = 0.21	−9.13 ± 0.94	0.38 (0.21, 0.53); P < 0.0001
CST (vagina)	2.39 ± 0.27	0.08 (−0.10, 0.25); P = 0.40	−0.76 ± 0.33	0.12 (−0.07, 0.30); P = 0.23
Algesiometer	10.70 ± 0.63	−0.16 (−0.33, 0.00); P = 0.06	5.68 ± 1.14	−0.33 (−0.49,−0.15); P = 0.0004
Pelvic muscle pain (mean)	0.64 ± 0.05	−0.09 (−0.25, 0.08); P = 0.34	−0.17 ± 0.05	0.12 (−0.06, 0.30); P = 0.19
SF-MPQ total score	13.56 ± 0.76	0.15 (−0.03, 0.31); P = 0.11	−4.92 ± 0.74	0.23 (0.04, 0.40); P = 0.02
SF-MPQ affective subscale	2.50 ± 0.27	0.13 (−0.04, 0.30); P = 0.16	−1.27 ± 0.26	0.16 (−0.03, 0.33); P = 0.12
SF-MPQ sensory subscale	10.96 ± 0.60	0.19 (0.02, 0.35), P = 0.054	−3.73 ± 0.58	0.30 (0.12, 0.46); P = 0.0052
Brief Pain Inventory	20.46 ± 1.60	0.34 (0.17, 0.48); P < 0.0001	−7.91 ± 1.60	0.49 (0.34, 0.62); P < 0.0001
Neuropathic Pain Scale	43.69 ± 1.37	0.19 (0.01, 0.35); P = 0.03	−12.7 ± 1.52	0.33 (0.16, 0.49); P = 0.0005
Beck Depression Inventory	9.58 ± 0.79	0.03 (−0.14, 0.21); P = 0.71	**	**
Profile of Mood States	86.68 ± 2.75	0.10 (−0.07, 0.27); P = 0.29	**	**

SF-MPQ = Short-form McGill Pain Questionnaire

^*Pearson Correlation Coefficient (95% C.I.)

^**not available at Week—8

CST = Cotton Swab Test

TT = Tampon Test